(Total Views: 175)
Posted On: 01/24/2024 7:49:50 AM
Post# of 47
AXOGEN: REPAIRING LIVES OF PATIENTS WITH PERIPHERAL NERVE INJURIES
$AXGN
Excited to share an article about Axogen, Inc. (NASDAQ: AXGN), a leader in developing and marketing innovative surgical solutions for peripheral nerve injuries.
For Q3 FY23, the Company's revenue was $41.3 million, an increase of approximately 12% over Q3 FY22. For FY23, revenue guidance is in the range of $154 million to $159 million, which represents annual growth of 11% - 15% and a gross margin of 80%.
The Company operates in the nerve industry, with a market opportunity of more than $2.7 billion. Since 2016, it has grown at a CAGR of 22%. It seems that Axogen will continue on this upward trajectory, making it an interesting watch.
Read on to know more
https://www.aviseanalytics.com/axogen-repairi...-injuries/
$AXGN
Excited to share an article about Axogen, Inc. (NASDAQ: AXGN), a leader in developing and marketing innovative surgical solutions for peripheral nerve injuries.
For Q3 FY23, the Company's revenue was $41.3 million, an increase of approximately 12% over Q3 FY22. For FY23, revenue guidance is in the range of $154 million to $159 million, which represents annual growth of 11% - 15% and a gross margin of 80%.
The Company operates in the nerve industry, with a market opportunity of more than $2.7 billion. Since 2016, it has grown at a CAGR of 22%. It seems that Axogen will continue on this upward trajectory, making it an interesting watch.
Read on to know more
https://www.aviseanalytics.com/axogen-repairi...-injuries/
(0)
(0)
